PROCESS FOR THE PREPARATION OF NON-HUMAN PRIMATES CD4 POLYPEPTIDEES, HUMAN CD4 MOLECULES, CAPABLE OF GLYCOSYLACAO, ITS FRAGMENTS, ITS FUSAO PROTEINS, GENETIC SEQUENCES, AND THEIR UTILIZATION

摘要

The invention relates to substantially pure non-human primate CD4, and fragments thereof which bind to HIV or SIV gp120. The invention also relates to gp120 binding molecules related to human CD4 but which may exist in glycosylated form. The invention also relates to fusion proteins which comprise the CD4 molecules of the invention, or fragments thereof, and an immunoglobulin light or heavy chain, wherein the variable region of the light or heavy chain has been replaced with CD4 or fragment thereof which is capable of binding to gp120. The invention also relates to fusion proteins comprising the CD4 molecules of the invention and a cytotoxic polypeptide. The invention also relates to an immunoglobulin-like molecules comprising the fusion proteins of the invention together with an immunoglobulin light or heavy chain. The invention also relates to methods of treating HIV or SIV infection comprising administering the CD4 molecules of the invention, glycoproteins, fragments thereof, fusion proteins or immunoglobulin-like molecules of the invention to an animal. The invention also relates to assays for HIV or SIV comprising contacting a sample suspected of containing HIV or SIV gp120 with the CD4 molecules of the invention, fragments thereof, glycoproteins, immunoglobulin-like molecules, or fusion proteins of the invention, and detecting whether a complex is formed. The invention also relates to nucleic acid molecules which specify the proteins, glycoproteins and fusion proteins of the invention as weil as vectors and transformed hosts.